Skip to Content
  • Revenues ($M)$181,241
  • Revenue Percent Change31.3%
  • Profits ($M)$1,476
  • Profits Percent Change16.9%
  • Assets ($M)$53,870
  • Employees70,400
  • Market Value — as of March 31, 2016 ($M)$35,945
  • Previous Rank11
  • Morning Consult Brand Index
    D

McKesson, the largest U.S. pharmaceutical distributor, is facing some major obstacles these days. After years of strong sales growth thanks to generic drug price inflation, the tailwind is expected to slow and cut into the company’s overall revenue growth in 2015. McKesson also recently lost a handful of customers and could potentially lose another $13 billion worth of revenue in 2018 when (or if) Rite Aid is acquired by Walgreens. Management has been working on a series of maneuvers to lessen these blows, including acquiring strategic bolt-on companies to replace lost business and implementing a restructuring plan that’s expected to generate about $180 million in savings this fiscal year.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
John H. Hammergren
Sector
Health Care
Industry
Wholesalers: Health Care
HQ Location
San Francisco, CA
Websitehttp://www.mckesson.com
Years on Fortune 500 List22
Employees70,400
Figures are for fiscal year ended March 31, 2015.

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$181,24131.3%
Profits ($M)$1,47616.9%
Assets ($M)$53,870-
Total Stockholder Equity ($M)$8,001-
Market Value — as of March 31, 2016 ($M)$35,945-

Profit Ratios

Profit as % of Revenues0.8%
Profits as % of Assets2.7%
Profits as % of Stockholder Equity18.4%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)6.27
EPS % Change (from 2014)15.9%
EPS % Change (5 year annual rate)6.3%
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2015)-4.5%
Total Return to Investors (5 year, annualized)23.8%
Total Return to Investors (10 year, annualized)15.2%